A1CD2 - ARCSA Registration c1ade292661f5e5e94fbe4026b4cbda2
Access comprehensive regulatory information for A1CD2 in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID c1ade292661f5e5e94fbe4026b4cbda2 and manufactured by ROCHE DIAGNOSTICS GMBH. The device was registered on November 27, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
II
c1ade292661f5e5e94fbe4026b4cbda2
A1CD2
ARCSA ID: c1ade292661f5e5e94fbe4026b4cbda2
Device Classification
Risk Class
II
Product Type
In Vitro Diagnostic
Brand Name
ROCHE
Commercial Name
18-904 IVD Reagents/Test Kits, Clinical Chemistry, Protein, Glycosylated, Hemoglobin
Registration Information
Analysis ID
c1ade292661f5e5e94fbe4026b4cbda2
Registration Date
November 27, 2023
Expiration Date
November 27, 2028
Product Use
DILUYENTE OF THE TIN-QUANT HEMOGLOBIN A1C TEST.
Manufacturer
Product Owner
Name
ROCHE DIAGNOSTICS GMBH
Country
GERMANY
Authorized Representative